atovaquone 750 MG in 5 mL Oral Suspension
- RxCUI
- 308429
- RxNorm name
- atovaquone 750 MG in 5 mL Oral Suspension
- Display name
- atovaquone 750 MG in 5 mL Oral Suspension
- Full name
- atovaquone 750 MG in 5 mL Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:17
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atovaquone Oral Suspension | ATOVAQUONE | KVK-Tech, Inc. | b31ff20a-c363-4be0-9bc0-3081c163b63c | 2026-06-16 | Warnings, Adverse reactions | 308429 |
| ATOVAQUONE | ATOVAQUONE | AvKARE | 54423fee-da60-25dc-e063-6294a90a2552 | 2026-06-14 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Camber Pharmaceuticals, Inc. | 2445304e-4b4e-4358-b098-31f3c49c52ef | 2026-06-10 | Warnings, Adverse reactions | 308429 |
| atovaquone | ATOVAQUONE | Glenmark Pharmaceuticals Inc., USA | 9045ba6f-938e-4717-bfa2-a3efe52f04cd | 2026-05-06 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | PAI Holdings, LLC dba PAI Pharma | df6086d3-6100-422a-bf23-e9610027749b | 2026-04-30 | Warnings, Adverse reactions | 308429 |
| ATOVAQUONE | ATOVAQUONE | Amneal Pharmaceuticals LLC | b7398fcf-522a-488a-8dd6-051561f62804 | 2026-04-29 | Warnings, Adverse reactions | 308429 |
| MEPRON | ATOVAQUONE | GlaxoSmithKline LLC | b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | 2026-03-20 | Warnings, Adverse reactions | 308429 |
| Atovaquone Oral Suspension | ATOVAQUONE | Kesin Pharma Corporation | 4a2e2c4b-85aa-9b30-e063-6294a90a7bd9 | 2026-02-06 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Golden State Medical Supply, Inc. | ddbfe1a9-df9b-79b0-e053-2995a90acc9b | 2025-12-17 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Bionpharma Inc. | bff4f4fc-6307-f414-e053-2a95a90ac0de | 2025-12-04 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Chartwell Governmental & Specialty RX, LLC. | e6770b85-54f8-4969-af02-7d81586be761 | 2025-11-07 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | American Health Packaging | 1a8a43a2-bc26-4ee5-aa35-22a5477a7129 | 2025-10-17 | Warnings, Adverse reactions | 308429 |
| ATOVAQUONE | ATOVAQUONE | AvPAK | 4124ad97-f6b9-8afb-e063-6294a90ab970 | 2025-10-14 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | 40331de7-819e-5965-e063-6294a90ac91d | 2025-10-01 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Kesin Pharma | 16b69156-e5de-c601-e063-6394a90afeae | 2025-09-15 | Warnings, Adverse reactions | 308429 |
| ATOVAQUONE | ATOVAQUONE ORAL SUSPENSION | Major Pharmaceuticals | 73e2297e-7cda-4abf-9fb7-8c67cb5638a3 | 2025-08-13 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | f99a8a0c-2b42-4da0-8f5a-e963fc619e8b | 2025-05-12 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Abon Pharmaceuticals, LLC | 2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08 | 2025-05-12 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | Lohxa | ba3cad0d-cce9-424f-ba5c-557dba8bef12 | 2025-03-20 | Warnings, Adverse reactions | 308429 |
| Atovaquone | ATOVAQUONE | A2A Integrated Pharmaceuticals, LLC | 27d64592-5078-6122-e063-6394a90ae074 | 2025-01-02 | Warnings, Adverse reactions | 308429 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 27 | These highlights do not include all the information needed to use MEPRON oral suspension safely and effectively. See full prescribing information for MEPRON oral suspension. MEPRON (atovaquone oral suspension) Initial U.S. Approval: 1992 | 20260320 |
| b7398fcf-522a-488a-8dd6-051561f62804 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 24 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20260429 |
| df6086d3-6100-422a-bf23-e9610027749b | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 13 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20260430 |
| 2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 12 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20250512 |
| 9045ba6f-938e-4717-bfa2-a3efe52f04cd | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 9 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20260506 |
| b31ff20a-c363-4be0-9bc0-3081c163b63c | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 7 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension, for oral use Initial U.S. Approval: 1992 | 20240215 |
| 73e2297e-7cda-4abf-9fb7-8c67cb5638a3 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 6 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20250813 |
| bff4f4fc-6307-f414-e053-2a95a90ac0de | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 5 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20251204 |
| 1a8a43a2-bc26-4ee5-aa35-22a5477a7129 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 5 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20251017 |
| 16b69156-e5de-c601-e063-6394a90afeae | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 5 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20250915 |
| ddbfe1a9-df9b-79b0-e053-2995a90acc9b | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 4 | ATOVAQUONE ORAL SUSPENSION These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20251217 |
| 2445304e-4b4e-4358-b098-31f3c49c52ef | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 4 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20240402 |
| 2a7b2c9c-dbdd-41a8-a0eb-e3af4d8212be | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 4 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20240214 |
| f99a8a0c-2b42-4da0-8f5a-e963fc619e8b | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 2 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20250512 |
| ba3cad0d-cce9-424f-ba5c-557dba8bef12 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 2 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20250320 |
| 27d64592-5078-6122-e063-6394a90ae074 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 2 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION, USP safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION, USP. Atovaquone oral suspension, USP Initial U.S. Approval: 1992 | 20250102 |
| de0e29b5-a4c7-405c-a5b9-438729d9ba3a | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 2 | ATOVAQUONE Oral Suspension These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE Oral Suspension Initial U.S. Approval: 1992 | 20240524 |
| 4a2e2c4b-85aa-9b30-e063-6294a90a7bd9 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 1 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension, for oral use Initial U.S. Approval: 1992 | 20260206 |
| e6770b85-54f8-4969-af02-7d81586be761 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 1 | ATOVAQUONE Oral Suspension These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE Oral Suspension Initial U.S. Approval: 1992 | 20251107 |
| 4124ad97-f6b9-8afb-e063-6294a90ab970 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 1 | ATOVAQUONE Oral Suspension, USP Rx Only These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. Initial U.S. Approval: 1992 | 20251014 |
| 40331de7-819e-5965-e063-6294a90ac91d | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 1 | ATOVAQUONE ORAL SUSPENSION. These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20251001 |
| fc7bdd97-f780-4eed-80e0-72e70267b21a | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 1 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20240412 |
| 03ddcc33-729c-4d46-ae6b-2ee47978ba16 | atovaquone 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [SCD] · atovaquone 1500 MG per 10 ML Oral Suspension [SY] · atovaquone 750 MG per 5 ML Oral Suspension [SY] | 4 | 1 | These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992 | 20210601 |